By using messenger ribonucleic acid (or mRNA) as a platform for delivering vaccinations, biotech companies like Moderna have been able to rewrite COVID vaccines swiftly to address newly-emergent variant strains. And now, fighting COVID is just the beginning, as Moderna plans to use mRNA to change the way we treat or prevent other diseases. National Public Radio correspondent Allison Aubrey reports.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.